These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2856222)

  • 41. Bluetongue: diagnostic/antigenic interpretation.
    Campbell CH
    Prog Clin Biol Res; 1985; 178():435-43. PubMed ID: 2989883
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative evaluation of sensitivity of RNA-polyacrylamide gel electrophoresis and dot immunobinding assay for detection of bluetongue virus in cell culture.
    Prasad G; Minakshi
    Indian J Exp Biol; 1999 Feb; 37(2):157-60. PubMed ID: 10641136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plaque neutralization cross reactivity of post infection bovine sera amongst bluetongue virus serotypes.
    Thomas FC
    Prog Clin Biol Res; 1985; 178():511-2. PubMed ID: 2989894
    [No Abstract]   [Full Text] [Related]  

  • 45. Bluetongue and related orbivirus diagnosis in the United States.
    Pearson JE; Carbrey EA; Gustafson GA
    Prog Clin Biol Res; 1985; 178():469-75. PubMed ID: 2989887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep.
    Hunter P; Modumo J
    Onderstepoort J Vet Res; 2001 Dec; 68(4):331-3. PubMed ID: 12026066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of antibody-ELISA and real-time RT-PCR for the diagnosis and profiling of bluetongue virus serotype 8 during the epidemic in Belgium in 2006.
    Vandenbussche F; Vanbinst T; Verheyden B; Van Dessel W; Demeestere L; Houdart P; Bertels G; Praet N; Berkvens D; Mintiens K; Goris N; De Clercq K
    Vet Microbiol; 2008 May; 129(1-2):15-27. PubMed ID: 18093753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The epidemiology and diagnosis of bluetongue with particular reference to Corsica.
    Breard E; Hamblin C; Hammoumi S; Sailleau C; Dauphin G; Zientara S
    Res Vet Sci; 2004 Aug; 77(1):1-8. PubMed ID: 15120946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the relationship between bluetongue, African horsesickness and reoviruses: hybridization studies.
    Verwoerd DW; Huismans H
    Onderstepoort J Vet Res; 1969 Dec; 36(2):175-9. PubMed ID: 4342071
    [No Abstract]   [Full Text] [Related]  

  • 50. Experimental bluetongue infections in gnotobiotic lambs and kids.
    Livingston CW; McConnell S; Cummings G; Gauer BB
    Am J Vet Res; 1983 Jan; 44(1):129-31. PubMed ID: 6297338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of diagnostics for bluetongue.
    Jochim MM
    Prog Clin Biol Res; 1985; 178():423-33. PubMed ID: 2989881
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical and serological outcome following the simultaneous inoculation of three bluetongue virus types into sheep.
    Jeggo MH; Wardley RC; Taylor WP
    Res Vet Sci; 1984 Nov; 37(3):368-70. PubMed ID: 6097969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of an australian bluetongue virus isolate (CSIRO 19) with other bluetongue virus serotypes by cross-hybridization and cross-immune precipitation.
    Huismans H; Bremer CW
    Onderstepoort J Vet Res; 1981 Jun; 48(2):59-67. PubMed ID: 6273774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A molecular approach to the diagnosis of virus infections.
    Brown F
    Prog Brain Res; 1983; 59():1-10. PubMed ID: 6665124
    [No Abstract]   [Full Text] [Related]  

  • 55. Bluetongue virus structural components.
    Huismans H; Van Dijk AA
    Curr Top Microbiol Immunol; 1990; 162():21-41. PubMed ID: 2166647
    [No Abstract]   [Full Text] [Related]  

  • 56. Soluble antigen of blue-tongue virus.
    Wang CS; Lueker DC; Chow TL
    Infect Immun; 1972 Apr; 5(4):467-73. PubMed ID: 4344301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of bioengineering to disease diagnosis.
    Osburn BI
    Basic Life Sci; 1986; 37():195-205. PubMed ID: 3010934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies for the identification of icosahedral virus receptors.
    Bass DM; Greenberg HB
    J Clin Invest; 1992 Jan; 89(1):3-9. PubMed ID: 1309536
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunoblotting and related techniques.
    Flanagan TD
    J Allergy Clin Immunol; 1985 Oct; 76(4):527-9. PubMed ID: 3902936
    [No Abstract]   [Full Text] [Related]  

  • 60. Application of molecular techniques to the diagnosis of bluetongue virus infection.
    Squire KR; Stott JL; Dangler CA; Osburn BI
    Prog Vet Microbiol Immunol; 1987; 3():235-50. PubMed ID: 2856222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.